Prelude Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,948	Closed	-$37K	–	1278
2020 Q3	$37K	Sell	1,948 -241	-11%	-$4.85K	0.01%	1197
2020 Q2	$49K	Buy	+2,189	New	+$40.1K	0.01%	1164
2019 Q4	–	Sell	-2,435	Closed	-$48K	–	1901
2019 Q3	$48K	Sell	2,435 -3,500	-59%	-$72.9K	0.01%	1168
2019 Q2	$125K	Sell	5,935 -3,000	-34%	-$62.7K	0.01%	875
2019 Q1	$183K	Buy	8,935 +5,388	+152%	+$121K	0.02%	740
2018 Q4	$71K	Buy	+3,547	New	+$69.9K	0.01%	1027
2018 Q2	–	Sell	-1,750	Closed	-$33K	–	1650
2018 Q1	$33K	Buy	+1,750	New	+$32.9K	﹤0.01%	1185
2017 Q2	–	Sell	-2,326	Closed	-$34K	–	1584
2017 Q1	$34K	Sell	2,326 -7,943	-77%	-$125K	﹤0.01%	1149
2016 Q4	$189K	Sell	10,269 -17,449	-63%	-$339K	0.02%	602
2016 Q3	$526K	Buy	27,718 +6,640	+32%	+$121K	0.08%	302
2016 Q2	$340K	Buy	21,078 +2,000	+10%	+$28.2K	0.05%	359
2016 Q1	$229K	Sell	19,078 -7,400	-28%	-$87.2K	0.04%	508
2015 Q4	$377K	Buy	26,478 +5,400	+26%	+$71.3K	0.07%	348
2015 Q3	$246K	Buy	+21,078	New	+$316K	0.04%	499